# APLENZIN
> **NDA022108** · New Drug Application · Sponsor: BAUSCH · Approved 2008-04-23
## Drug
- **FDA Application Number:** NDA022108
- **Application type:** New Drug Application
- **Brand name:** APLENZIN
- **Generic name:** BUPROPION HYDROBROMIDE
- **Active ingredients:** BUPROPION HYDROBROMIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BAUSCH
- **Manufacturer:** Bausch Health US, LLC
- **First approval:** 2008-04-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022108)
---
*AI Analytics · CC0 1.0*